Glimiteris M1 & Glimepiride & Metformin Hydrochloride Prolonged Release.

Introduction

GLIMITERIS M1 is a highly effective oral antidiabetic medication designed to manage type 2 diabetes mellitus. It combines two potent agents: Glimepiride 1 mg and Metformin Hydrochloride Prolonged Release 500 mg, offering a dual mechanism of action to control blood glucose levels effectively. This fixed-dose combination improves insulin secretion and enhances insulin sensitivity, making it a powerful and convenient treatment option for diabetic patients.

Understanding the Ingredients

• Glimepiride (1 mg)

Glimepiride is a sulfonylurea class medication that stimulates the pancreas to release more insulin, thereby lowering blood sugar levels. It is known for its once-daily dosing convenience and long-lasting effect.

• Metformin Hydrochloride Prolonged Release (500 mg)

Metformin is a biguanide antidiabetic agent that primarily reduces hepatic glucose production and improves insulin sensitivity in peripheral tissues. The prolonged-release formulation ensures a steady release of the medication over time, enhancing tolerability and minimizing gastrointestinal side effects.

Uses of GLIMITERIS M1

GLIMITERIS M1, containing glimepiride and metformin hydrochloride, is prescribed for:

• Management of Type 2 Diabetes Mellitus: Especially when diet, exercise, and monotherapy with either glimepiride or metformin alone are insufficient.

• Improvement of Glycemic Control: By combining insulin secretion enhancement with reduced glucose production.

• Reduced Risk of Complications: Effective glycemic control with glimepiride 1 mg and metformin 500 mg helps prevent diabetes-related complications like neuropathy, nephropathy, and retinopathy.

Mechanism of Action

• Glimepiride increases insulin secretion from the beta cells of the pancreas.

• Metformin hydrochloride prolonged release decreases glucose production in the liver, reduces intestinal glucose absorption, and improves insulin sensitivity.

Together, they provide a complementary approach to blood sugar management, ensuring comprehensive glycemic control.

Dosage and Administration

The dosage of GLIMITERIS M1 should be individualized based on the patient's current regimen, effectiveness, and tolerance.
It is generally recommended to be taken once daily with breakfast or the first main meal to reduce the risk of hypoglycemia.

Always follow your healthcare provider’s instructions for optimal results and safety.

Benefits of GLIMITERIS M1

• Dual Mechanism: Combines insulin secretion and sensitivity improvement.

• Convenient Dosing: One tablet formulation improves patient adherence.

• Steady Glycemic Control: Thanks to the metformin hydrochloride prolonged release formulation.

• Reduced Side Effects: Prolonged-release metformin minimizes gastrointestinal discomfort.

Side Effects of GLIMITERIS M1

While GLIMITERIS M1 is generally well-tolerated, some potential side effects include:

• Hypoglycemia (low blood sugar)

• Nausea or vomiting

• Diarrhea

• Stomach upset

• Headache

• Weight gain (due to glimepiride)

• Rarely, lactic acidosis (with metformin)

Seek immediate medical attention if you experience symptoms like extreme weakness, difficulty breathing, or unusual muscle pain.

Frequently Asked Questions (FAQ)

Q1: What is GLIMITERIS M1 used for?

GLIMITERIS M1 is used for the effective management of type 2 diabetes mellitus when diet, exercise, and monotherapy do not provide adequate blood sugar control.

Q2: How does glimepiride and metformin hydrochloride work together?

Glimepiride stimulates insulin release, while metformin reduces liver glucose production and improves insulin sensitivity, offering a complementary effect on blood glucose control.

Q3: Can I experience side effects while taking GLIMITERIS M1?

Some common side effects include mild hypoglycemia, nausea, or stomach upset. Serious side effects are rare but require immediate medical attention.

Q4: When should GLIMITERIS M1 be taken?

It is usually taken once daily with food to minimize the risk of low blood sugar and gastrointestinal side effects.

Q5: Is GLIMITERIS M1 suitable for everyone with type 2 diabetes?

Not all patients are ideal candidates. Always consult your doctor before starting glimepiride and metformin hydrochloride tablets to ensure suitability.

Conclusion

GLIMITERIS M1, combining glimepiride 1 mg and metformin hydrochloride prolonged release 500 mg, provides a powerful, dual-action approach to controlling type 2 diabetes mellitus. Its ability to stimulate insulin secretion and improve insulin sensitivity makes it a valuable choice for patients requiring better blood sugar management. With proper medical guidance, GLIMITERIS M1 can significantly improve glycemic control and overall quality of life.

About The Author

STERIS HEALTHCARE PVT LTD

Steris Healthcare Pvt Ltd, known as Sterispharma, was founded in February 2018 by a team of experienced professionals in the pharmaceutical industry. Headquartered in Navi Mumbai, the company holds certifications from WHO, GMP, and ISO, reflecting its dedication to maintaining high standards of quality and safety. Sterispharma’s mission is to provide affordable, high-quality medications across India, strictly adhering to WHO guidelines. With the convenience of an online pharmacy, customers can easily order medicines with home delivery options.

For further information 

Email: info@sterispharma.com / contact@sterispharma.com

Call/WhatsApp: 8209542042 , 8824175417

BUY NOW